XKRX
108860
Market cap201mUSD
Dec 05, Last price
12,720.00KRW
1D
-1.78%
1Q
-3.12%
Jan 2017
195.47%
IPO
207.74%
Name
Selvas AI Inc
Chart & Performance
P/E
—
P/S
2.63
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.35%
Rev. gr., 5y
25.99%
Revenues
112.45b
+112.13%
Net income
-5.81b
L+127.62%
CFO
5.23b
+29.71%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Selvas AI Inc. operates as an artificial intelligence (AI) company in South Korea. The company offers Selvy Note, an AI Voice Record for recognizing the content of conversations such as research, consultation, and meetings; Selvy MediVoice, an AI medical voice recognition that generates medical records during the medical process through voice; Selvy SpeechEdu, an AI training voice recognition for text utilization learning, sentence pronunciation accuracy learning, and sophisticated pronunciation at the phoneme/phonetic level. It also provides odiro, an AI voice content creation solution; Selvy Alrimi, an AI announcement solution to enter the broadcast content as text and the announcement voice can be automatically transmitted at the desired time; Selvy Checkup, an AI disease occurrence probability prediction solution; OnFit, an IoT-based smart fitness/fitness membership management program; Selpub, a cloud-based multimedia eBook; and DIODICT, a mobile electronic dictionary. The company was formerly known as DIOTEK Co., Ltd. and changed its name to Selvas AI Inc. in September 2016. Selvas AI Inc. was founded in 1999 and is based in Seoul, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||